TY - JOUR
T1 - An Atypical Form of Diabetes Among Individuals With Low BMI
AU - Lontchi-Yimagou, Eric
AU - Dasgupta, Riddhi
AU - Anoop, Shajith
AU - Kehlenbrink, Sylvia
AU - Koppaka, Sudha
AU - Goyal, Akankasha
AU - Venkatesan, Padmanaban
AU - Livingstone, Roshan
AU - Ye, Kenny
AU - Chapla, Aaron
AU - Carey, Michelle
AU - Jose, Arun
AU - Rebekah, Grace
AU - Wickramanayake, Anneka
AU - Joseph, Mini
AU - Mathias, Priyanka
AU - Manavalan, Anjali
AU - Kurian, Mathews Edatharayil
AU - Inbakumari, Mercy
AU - Christina, Flory
AU - Stein, Daniel
AU - Thomas, Nihal
AU - Hawkins, Meredith
N1 - Funding Information:
chromatography–mass spectrometry measurements (from Albert Einstein College of Medicine) and Robin Sgueglia and the staff of the Albert Einstein College of Medicine Clinical Research Center and Einstein Hormone Assay Core of Einstein-Mount Sinai Diabetes Research Center. The authors also thank the subjects who participated in the study. Funding. This study was supported by the Global Diabetes Institute of the Albert Einstein College of Medicine. The Assay Core of the Einstein-Mount Sinai Diabetes Research Center was supported by P60 DK20541. Duality of Interest. No potential conflicts of interest relevant to this article were reported. Author Contributions. E.L.-Y. and R.D. performed clamp studies, collected and analyzed data, and wrote the manuscript. S.A., S.Ke., S.Ko., A.G., and M.E.K. performed clamp studies, collected data, and contributed to writing the manuscript. P.V., K.Y., A.C., M.C., A.J., G.R., A.W., M.J., P.M., A.M., M.I., and F.C. assisted with data analysis and contributed to writing the manuscript. D.S. provided oversight for the project and critically edited the manuscript. N.T. and M.H. supervised the clamp studies, data collection and analysis, and manuscript preparation. All of the authors edited and approved the final manuscript. M.H. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Prior Presentation. Parts of this study were presented in abstract form at the 80th Scientific Sessions of the American Diabetes Association, 12–16 June 2020.
Publisher Copyright:
© 2022 by the American Diabetes Association.
PY - 2022/6
Y1 - 2022/6
N2 - OBJECTIVE Diabetes among individuals with low BMI (<19 kg/m2) has been recognized for >60 years as a prevalent entity in low-and middle-income countries (LMICs) and was formally classified as “malnutrition-related diabetes mellitus” by the World Health Organization (WHO) in 1985. Since the WHO withdrew this category in 1999, our objective was to define the metabolic characteristics of these individuals to establish that this is a distinct form of diabetes. RESEARCH DESIGN AND METHODS State-of-the-art metabolic studies were used to characterize Indian individuals with “low BMI diabetes” (LD) in whom all known forms of diabetes were excluded by immunogenetic analysis. They were compared with demographically matched groups: a group with type 1 diabetes (T1D), a group with type 2 diabetes (T2D), and a group without diabetes. Insulin secretion was assessed by C-peptide deconvolution. Hepatic and peripheral insulin sensitivity were analyzed with stepped hyperinsulinemic-euglycemic pancreatic clamp studies. Hepatic and myocellular lipid contents were assessed with1H-nuclear magnetic resonance spectroscopy. RESULTS The total insulin secretory response was lower in the LD group in comparison with the lean group without diabetes and the T2D group. Endogenous glucose production was significantly lower in the LD group than the T2D group (mean ± SEM 0.50 ± 0.1 vs. 0.84 ± 0.1 mg/kg · min, respectively; P < 0.05). Glucose uptake was significantly higher in the LD group in comparison with the T2D group (10.1 ± 0.7 vs. 4.2 ± 0.5 mg/kg · min; P < 0.001). Visceral adipose tissue and hepatocellular lipids were significantly lower in LD than in T2D. CONCLUSIONS These studies are the first to demonstrate that LD individuals in LMICs have a unique metabolic profile, suggesting that this is a distinct entity that warrants further investigation.
AB - OBJECTIVE Diabetes among individuals with low BMI (<19 kg/m2) has been recognized for >60 years as a prevalent entity in low-and middle-income countries (LMICs) and was formally classified as “malnutrition-related diabetes mellitus” by the World Health Organization (WHO) in 1985. Since the WHO withdrew this category in 1999, our objective was to define the metabolic characteristics of these individuals to establish that this is a distinct form of diabetes. RESEARCH DESIGN AND METHODS State-of-the-art metabolic studies were used to characterize Indian individuals with “low BMI diabetes” (LD) in whom all known forms of diabetes were excluded by immunogenetic analysis. They were compared with demographically matched groups: a group with type 1 diabetes (T1D), a group with type 2 diabetes (T2D), and a group without diabetes. Insulin secretion was assessed by C-peptide deconvolution. Hepatic and peripheral insulin sensitivity were analyzed with stepped hyperinsulinemic-euglycemic pancreatic clamp studies. Hepatic and myocellular lipid contents were assessed with1H-nuclear magnetic resonance spectroscopy. RESULTS The total insulin secretory response was lower in the LD group in comparison with the lean group without diabetes and the T2D group. Endogenous glucose production was significantly lower in the LD group than the T2D group (mean ± SEM 0.50 ± 0.1 vs. 0.84 ± 0.1 mg/kg · min, respectively; P < 0.05). Glucose uptake was significantly higher in the LD group in comparison with the T2D group (10.1 ± 0.7 vs. 4.2 ± 0.5 mg/kg · min; P < 0.001). Visceral adipose tissue and hepatocellular lipids were significantly lower in LD than in T2D. CONCLUSIONS These studies are the first to demonstrate that LD individuals in LMICs have a unique metabolic profile, suggesting that this is a distinct entity that warrants further investigation.
UR - http://www.scopus.com/inward/record.url?scp=85131270831&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131270831&partnerID=8YFLogxK
U2 - 10.2337/dc21-1957
DO - 10.2337/dc21-1957
M3 - Article
C2 - 35522035
AN - SCOPUS:85131270831
SN - 0149-5992
VL - 45
SP - 1428
EP - 1437
JO - Diabetes care
JF - Diabetes care
IS - 6
ER -